Karnataka should explore dedicated investment mechanisms for BT: Mazumdar-Shaw
Kiran Mazumdar-Shaw has urged the Karnataka government to establish dedicated investment mechanisms for the biotechnology sector. The proposal emphasizes integrating AI into the biotech value chain to boost drug discovery, diagnostics, and biomanufacturing in the state.
Why it matters
Strategic investment in biotechnology and AI integration is critical for maintaining regional economic competitiveness and advancing healthcare innovation.
Karnataka should explore dedicated biotechnology investment mechanisms while embedding artificial intelligence across the biotechnology value chain to unlock new opportunities in drug discovery, diagnostics, precision medicine, and biomanufacturing, said Kiran Mazumdar-Shaw, Chairperson, Vision Group on Biotechnology.
The article provides a straightforward account of a business-focused government meeting and industry recommendations.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in